(Q53323047)

English

Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

scientific article published in October 1996

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

author name string

McLaurin J

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

Chakrabartty A

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

language of work or name

0 references

publication date

1 October 1996

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

271

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

43

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

26482-26489

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Cleavage of amyloid beta peptide during constitutive processing of its precursor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Alzheimer's amyloid of another flavour.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Beta APP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Alzheimer's disease. In search of the soluble

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Determination of the helix and beta form of proteins in aqueous solution by circular dichroism.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

A familial Alzheimer's disease locus on chromosome 1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

pH-dependent structural transitions of Alzheimer amyloid peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.43.26482

21 January 2018

Identifiers

10.1074/JBC.271.43.26482

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8900116

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53323047&oldid=1770434297"